urolithiasis renal stone
Conditions
Interventions
Tria group: 6Fr TriaTM ureteral stent placement at the end of the surgery
Percu group:6Fr PercuflexTM ureteral stent placement at the end of the surgery
InLay group:6Fr InLay Optima ureteral stent pla
D000074266
Endoscopic lithotripsy, ureteral stent
Sponsors
Hamamoto Shuzo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients whose age are between 16 and 80 years old, diagnosed with renal and/or upper ureteral stone at Nagoya City University Hospital, and planned for endoscopic surgery 2) Eastern Cooperative Oncology Group (ECOG) Performance status (PS) 0 or 1 3) Patients who were obtained written informed consent - obtained written informed consent from themselves if they are 20 years old and older - obtained written informed consent from themselves and representatives are between 16 and 19 years old
Exclusion criteria
Exclusion criteria: A)women with pregnant or its possibility B)difficult status for general/lumber anesthesia judged by anesthesiologist C)nephrostomy placement after surgery D)patients with urinary diversion
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.stent encrustation 2.Bacteria attachment to the ureteral stent | — |
Secondary
| Measure | Time frame |
|---|---|
| ureteral stent symptom, surgeon questionnaire as regard to stent insertion and removal, stent location, perioperative complication | — |
Contacts
Public ContactShuzo Hamamoto
Nagoya City University Hospital
Outcome results
None listed